Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients-Reference-Cited by-同舟云学术

Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients

Published:2017-06-06 Issue:2 Volume:23 Page:142-146
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Jabir Rafid Salim¹,Ho Gwo Fuang²,Annuar Muhammad Azrif Bin Ahmad³,Stanslas Johnson¹

Affiliation:

1. Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia;

2. Clinical Oncology Unit, University Malaya Medical Centre, Kuala Lumpur, Malaysia;

3. Radiotherapy & Oncology, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur, Malaysia

Funder

Ministry of Higher Education (MOHE), Malaysia

University Malaya

University Malaya, High Impact Research

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2017.1334152

Reference26 articles.

1. Relationship of systemic exposure to unbound docetaxel and neutropenia

2. Clinical Pharmacokinetics of Docetaxel

3. A population pharmacokinetic model for docetaxel (Taxotere®): Model building and validation

4. Investigation of genetic variants of α-1 acid glycoprotein by ultra-performance liquid chromatography–mass spectrometry

5. The prognostic significance of serum α1-acid glycoprotein changes in acute myocardial infarction

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers;International Journal of Molecular Sciences;2022-09-21

2. Characterization of alpha-1-acid glycoprotein as a potential biomarker for breast cancer;Bioengineered;2022-02-21

3. Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials;Clinical Pharmacology: Advances and Applications;2021-01

4. Serum α-1 Acid Glycoprotein is a Biomarker for the Prediction of Targeted Therapy Resistance in Advanced EGFR-positive Lung Adenocarcinoma;Combinatorial Chemistry & High Throughput Screening;2019-02-26